Incannex Healthcare (IXHL) Other Non-Current Liabilities (2020 - 2026)
Incannex Healthcare (IXHL) posted Other Non-Current Liabilities of $3.1 million for Q1 2026, up 132.98% sequentially from $1.3 million in Q1 2025, and up 132.98% YoY from $1.3 million in Q1 2025.
Incannex Healthcare (IXHL) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Incannex Healthcare has reported Other Non-Current Liabilities for 4 years, with the latest figure at $3.1 million in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 132.98% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (up 132.98% YoY) and the FY2020 annual result came in at $116645.0, changed N/A from the prior year.
- Other Non-Current Liabilities advanced to $3.1 million in Q1 2026 per IXHL's latest filing, from $1.3 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $3.1 million in Q1 2026 and troughed at $1.3 million in Q4 2024.
- A 3-year average of $1.9 million and a median of $1.3 million in 2025 frame the typical range for Other Non-Current Liabilities.
- The widest YoY moves for Other Non-Current Liabilities: up 132.98% in 2026, down 132.98% in 2026.
- Over 3 years, Other Non-Current Liabilities stood at $1.3 million in 2024, then gained by 2.8% to $1.3 million in 2025, then surged by 132.98% to $3.1 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $3.1 million, $1.3 million, and $1.3 million for Q1 2026, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Incannex Healthcare | 42.23 Mn | 42.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.08 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Jun 30, 2020 | 116,645.00 |